Reliance Industries' share price has experienced significant fluctuations, facing its worst single-day drop in 1.5 years on ...

According to MarketsandMarkets™, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion ...

Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...

AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune and TVM Capital Life Science, is developing AP-101 for Amyotrophic Lateral ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

According to MarketsandMarkets, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion in 2025 to USD 9.94 ...

Market analysts are currently viewing the risk-reward profile favorably. The consensus rating remains "Strong Buy," with an average price target of $7.00, suggesting substantial upside potential. The ...

The market is likely to consolidate further with a negative bias. Below are some short-term trading ideas to consider on ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

I anticipate that the gold futures look ready to repeat slide of approximately 6% between Jan. 7-9, 2026, as same as between Dec. 29-31, 2025 despite Venezuela shock as the increasing selling pressure ...

Shift4 (FOUR) stock analysis: slowing revenue but improving margins, 20% short interest and big buyback raise short-squeeze ...